Announcements Trials
Browse Landscape

Phase

Phase NA 17Phase 2 8Phase 1 7Phase EARLY_PHASE1 3Phase 2/3 2Phase 1/2 2Phase 4 1Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Other solid neoplasm 1

Conditions

Colorectal Neoplasms 73Carcinoma, Hepatocellular 67Stomach Neoplasms 52Pancreatic Neoplasms 40Rectal Neoplasms 30Colonic Neoplasms 30Neoplasms 21Liver Neoplasms 20Esophageal Neoplasms 19Neoplasm Metastasis 16Cholangiocarcinoma 16Esophageal Squamous Cell Carcinoma 14Gallbladder Neoplasms 12Biliary Tract Neoplasms 12Lung Neoplasms 10Gastrointestinal Neoplasms 7Adenocarcinoma Of Esophagus 7Ovarian Neoplasms 6Prostatic Neoplasms 5Neoplasms by Site 5Bile Duct Neoplasms 5Adenocarcinoma 5Polyps 4Neoplasms by Histologic Type 4Melanoma 4Hematologic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Adenoma 4Recurrence 3

Interventions

Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Pancreatic Ductal Adenocarcinoma × Gastrointestinal × Clear all
NCT06079346 2024-08-13

STOP-PC

Mateon Therapeutics

Phase 2/3 Recruiting
455 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT05955157 2024-01-10

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

University of Malaya

Phase 2/3 Unknown
52 enrolled
GastrointestinalOther solid neoplasm

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡